Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY
NCT04789980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 799
Last updated 2025-09-12
Summary
The study objectives are to find out: 1) palliative chemotherapy patterns and prognosis in patients with locally advanced or metastatic pancreatic cancer in Korea's real clinical settings, and 2) reasons adopted by clinicians in choosing therapeutic drugs.
Conditions
Sponsors & Collaborators
-
Boryung Pharmaceutical Co., Ltd
lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-29
- Primary Completion
- 2025-06-24
- Completion
- 2025-06-24
Countries
- South Korea
Study Locations
More Related Trials
-
Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy
NCT00644618 ·Status: COMPLETED ·Phase: PHASE3
-
Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer
NCT05841420 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma
NCT03633734 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer
NCT01834170 ·Status: COMPLETED ·Phase: PHASE1
-
Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer
NCT01396668 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas
NCT03779464 ·Status: UNKNOWN ·Phase: PHASE2
-
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
NCT02981719 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients
NCT03278015 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients
NCT06046794 ·Status: RECRUITING ·Phase: NA
-
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
NCT02506842 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas
NCT00038701 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer
NCT02749136 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma
NCT01593475 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
NCT05257993 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer
NCT05026905 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer
NCT01458717 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
NCT01488552 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer
NCT01851174 ·Status: TERMINATED ·Phase: PHASE2
-
Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma
NCT01333124 ·Status: TERMINATED ·Phase: PHASE2
-
Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer
NCT01430052 ·Status: COMPLETED ·Phase: PHASE2
-
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
NCT03750669 ·Status: COMPLETED ·Phase: PHASE3
-
Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer
NCT03807999 ·Status: COMPLETED ·Phase: PHASE2
-
FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX
NCT04167007 ·Status: UNKNOWN ·Phase: PHASE3
-
Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma
NCT06229496 ·Status: RECRUITING ·Phase: PHASE1
-
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
NCT04233866 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2